CA Patent

CA2811990C — Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators

Assigned to Syntrix Biosystems Inc · Expires 2023-03-21 · 3y expired

What this patent protects

There is disclosed aminopyridine- and aminopyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include aminopyridine- and aminopyrimidinecarboxamide compounds. More specifically, there is disclosed a genus of…

USPTO Abstract

There is disclosed aminopyridine- and aminopyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include aminopyridine- and aminopyrimidinecarboxamide compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders. For example, the present disclosure provides compounds of fonnula (1) and formula (2): (see formula 1) (see formula 2)

Drugs covered by this patent

Patent Metadata

Patent number
CA2811990C
Jurisdiction
CA
Classification
—
Expires
2023-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Syntrix Biosystems Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.